Cited by 222Chemical Synthesis and AnalysisEstrogen and related hormone effectsProtein Structure and Dynamics

Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor–coactivator interactions

Open access
Leduc, Anne-Marie, Trent, John O., Wittliff, James L., Bramlett, Kelli S., Briggs, Stephen L., Chirgadze, Nikolay Y., Wang, Yong, Burris, Thomas P. +1 more·2003·Proceedings of the National Academy of Sciences

Abstract

The interaction between nuclear receptors and coactivators provides an arena for testing whether protein–protein interactions may be inhibited by small molecule drug candidates. We provide evidence that a short cyclic peptide, containing a copy of the LXXLL nuclear receptor box pentapeptide, binds tightly and selectively to estrogen receptor α. Furthermore, as shown by x-ray analysis, the disulfide-bridged nonapeptide, nonhelical in aqueous solutions, is able to adopt a quasihelical conformer while binding to the groove created by ligand attachment to estrogen receptor α. An i, i +3 linked analog, H-Lys-cyclo( d -Cys-Ile-Leu-Cys)-Arg-Leu-Leu-Gln–NH 2 (peptidomimetic estrogen receptor modulator 1), binds with a K i of 25 nM, significantly better than an i, i +4 bridged cyclic amide, as predicted by molecular modeling design criteria. The induction of helical character, effective binding, and receptor selectivity exhibited by this peptide analog provide strong support for this strategy. The stabilization of minimalist surface motifs may prove useful for the control of other macromolecular assemblies, especially when an amphiphilic helix is crucial for the strong binding interaction between two proteins.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1934759100

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [20]Sakakibara, S. (1971) in Chemistry and Biochemistry of Amino Acids, Peptides, and Proteins , ed. Weinstein, B. (Dekker, New York), Vol. 1, pp. 51-85.

Cited by

Sorted by citations

Authors
Leduc, A.-M., Trent, J. O., Wittliff, J. L., Bramlett, K. S., Briggs, S. L., Chirgadze, N. Y., Wang, Y., Burris, T. P., & Spatola, A. F.
Affiliations
  • University of Louisville (US)
  • Departments of Chemistry, Medicine, and Biochemistry and Molecular Biology and the Institute for Molecular Diversity and Drug Design, and James Graham Brown Cancer Center, University of Louisville, Louisville, KY 40292; and Lilly Research Laboratories, Indianapolis, IN 46285
Venue
Proceedings of the National Academy of Sciences
Published
2003-09-17
Volume
100
Issue
20
Pages
11273-11278
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2141267373
Cited by
222
References
46
Citations by year
2026: 3 · 2025: 4 · 2024: 7 · 2023: 3 · 2022: 5 · 2021: 9 · 2020: 9 · 2019: 11 · 2018: 11 · 2017: 6 · 2016: 18 · 2015: 11 · 2014: 14 · 2013: 13 · 2012: 13
FWCI
3.45
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Eli Lilly and Company
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chemical Synthesis and Analysis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
Keywords
cyclic peptides, estrogen receptor alpha, LXXLL motif, protein-protein interaction inhibitors, disulfide-bridged peptides, peptidomimetics, nuclear receptors, small molecule drug candidates
MeSH terms
Amino Acid Sequence, Circular Dichroism, Models, Molecular, Molecular Sequence Data, Peptides, Cyclic, Protein Conformation, Receptors, Steroid, Crystallography, X-Ray, Nuclear Magnetic Resonance, Biomolecular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review